Stock Analysts’ Updated EPS Estimates for January 23rd (AAPL, ABF, AET, AFCG, AGNC, AKBA, AMTB, APA, ARR, ARWR)

Stock Analysts’ updated eps estimates for Thursday, January 23rd:

Apple (NASDAQ:AAPL) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $325.00 price target on the stock.

Associated British Foods (LON:ABF) had its buy rating reiterated by analysts at Shore Capital.

Afentra (LON:AET) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 90 ($1.11) price target on the stock.

AFC Gamma (NASDAQ:AFCG) had its market perform rating reiterated by analysts at JMP Securities.

AGNC Investment (NASDAQ:AGNC) had its market perform rating reaffirmed by analysts at JMP Securities.

Akebia Therapeutics (NASDAQ:AKBA) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $7.50 price target on the stock.

Amerant Bancorp (NASDAQ:AMTB) had its overweight rating reiterated by analysts at Stephens. The firm currently has a $29.00 price target on the stock.

APA (NASDAQ:APA) had its sector perform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $32.00 price target on the stock.

ARMOUR Residential REIT (NYSE:ARR) had its market perform rating reiterated by analysts at JMP Securities.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $80.00 target price on the stock.

Astria Therapeutics (NASDAQ:ATXS) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $16.00 target price on the stock.

Banner (NASDAQ:BANR) had its overweight rating reiterated by analysts at Stephens. The firm currently has a $82.00 target price on the stock.

BHP Group (LON:BHP) had its hold rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 1,900 ($23.39) target price on the stock.

CACI International (NYSE:CACI) had its outperform rating reiterated by analysts at Raymond James. Raymond James currently has a $490.00 price target on the stock, up from their previous price target of $475.00.

Cadence Bank (NYSE:CADE) had its overweight rating reiterated by analysts at Stephens. They currently have a $42.00 target price on the stock.

Cherry Hill Mortgage Investment (NYSE:CHMI) had its market perform rating reissued by analysts at JMP Securities.

Coherus BioSciences (NASDAQ:CHRS) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $7.00 price target on the stock.

Chimera Investment (NYSE:CIM) had its market perform rating reaffirmed by analysts at JMP Securities.

CMC Markets (LON:CMCX) had its hold rating reaffirmed by analysts at Shore Capital.

Capricorn Energy (LON:CNE) had its buy rating reaffirmed by analysts at Shore Capital.

Concentra Group Holdings Parent (NYSE:CON) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $30.00 target price on the stock.

CVB Financial (NASDAQ:CVBF) had its equal weight rating reaffirmed by analysts at Stephens. Stephens currently has a $25.00 target price on the stock.

Darling Ingredients (NYSE:DAR) had its overweight rating reiterated by analysts at Stephens. They currently have a $52.00 target price on the stock.

Deckers Outdoor (NYSE:DECK) had its outperform rating reissued by analysts at Telsey Advisory Group. The firm currently has a $240.00 target price on the stock.

Dolby Laboratories (NYSE:DLB) had its buy rating reissued by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $100.00 target price on the stock.

Dynex Capital (NYSE:DX) had its market perform rating reissued by analysts at JMP Securities.

Electronic Arts (NASDAQ:EA) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $173.00 target price on the stock.

Ellington Financial (NYSE:EFC) had its market outperform rating reaffirmed by analysts at JMP Securities. The firm currently has a $14.00 price target on the stock.

Esperion Therapeutics (NASDAQ:ESPR) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $7.00 target price on the stock.

Esperion Therapeutics (NASDAQ:ESPR) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $16.00 price target on the stock.

Exelixis (NASDAQ:EXEL) had its market outperform rating reiterated by analysts at JMP Securities. They currently have a $41.00 price target on the stock.

First Advantage (NYSE:FA) had its outperform rating reissued by analysts at Royal Bank of Canada. They currently have a $22.00 target price on the stock.

Diamondback Energy (NASDAQ:FANG) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $210.00 target price on the stock.

Galapagos (NASDAQ:GLPG) had its underweight rating reiterated by analysts at Barclays PLC.

Genmab A/S (NASDAQ:GMAB) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $50.00 price target on the stock.

Halliburton (NYSE:HAL) had its sector perform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $34.00 price target on the stock.

Harbour Energy (LON:HBR) had its not rated rating reaffirmed by analysts at Shore Capital.

Hochschild Mining (LON:HOC) had its overweight rating reiterated by analysts at JPMorgan Chase & Co.. They currently have a GBX 300 ($3.69) target price on the stock.

Hoth Therapeutics (NASDAQ:HOTH) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $4.00 price target on the stock.

IntegraFin (LON:IHP) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a GBX 440 ($5.42) target price on the stock.

Incyte (NASDAQ:INCY) had its sector perform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $70.00 target price on the stock.

Iofina (LON:IOF) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 37.50 ($0.46) price target on the stock.

Inter Parfums (NASDAQ:IPAR) had its buy rating reissued by analysts at DA Davidson. The firm currently has a $163.00 price target on the stock.

Invesco Mortgage Capital (NYSE:IVR) had its market perform rating reaffirmed by analysts at JMP Securities.

Invesco (NYSE:IVZ) had its sector perform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $19.00 price target on the stock.

Johnson & Johnson (NYSE:JNJ) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $181.00 target price on the stock.

Kier Group (LON:KIE) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 210 ($2.59) target price on the stock.

Kooth (LON:KOO) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 580 ($7.14) price target on the stock.

AG Mortgage Investment Trust (NYSE:MITT) had its market outperform rating reissued by analysts at JMP Securities. The firm currently has a $8.50 price target on the stock.

Melrose Industries (LON:MRO) had its overweight rating reissued by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a GBX 850 ($10.46) target price on the stock.

Annaly Capital Management (NYSE:NLY) had its market perform rating reiterated by analysts at JMP Securities.

Origin Bancorp (NASDAQ:OBK) had its overweight rating reissued by analysts at Stephens. Stephens currently has a $42.00 price target on the stock.

Ocugen (NASDAQ:OCGN) had its buy rating reissued by analysts at Chardan Capital. Chardan Capital currently has a $6.00 price target on the stock.

Orchid Island Capital (NYSE:ORC) had its market perform rating reissued by analysts at JMP Securities.

Old Second Bancorp (NASDAQ:OSBC) had its overweight rating reaffirmed by analysts at Stephens. Stephens currently has a $21.00 price target on the stock.

Blue Owl Capital (NYSE:OWL) had its buy rating reaffirmed by analysts at Citigroup Inc.. They currently have a $30.00 price target on the stock.

PensionBee Group (LON:PBEE) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 217 ($2.67) target price on the stock.

Premier Foods (LON:PFD) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 240 ($2.95) target price on the stock.

Procter & Gamble (NYSE:PG) had its buy rating reissued by analysts at DA Davidson. DA Davidson currently has a $209.00 target price on the stock.

Procter & Gamble (NYSE:PG) had its sector perform rating reissued by analysts at Royal Bank of Canada. They currently have a $164.00 price target on the stock.

Precigen (NASDAQ:PGEN) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $6.00 target price on the stock, up from their previous target price of $4.00.

Pharos Energy (LON:PHAR) had its house stock rating reaffirmed by analysts at Shore Capital.

PennyMac Mortgage Investment Trust (NYSE:PMT) had its market outperform rating reissued by analysts at JMP Securities. They currently have a $15.50 price target on the stock.

Royal Caribbean Cruises (NYSE:RCL) had its outperform rating reissued by analysts at Mizuho. They currently have a $253.00 target price on the stock, down from their previous target price of $255.00.

Rithm Capital (NYSE:RITM) had its market outperform rating reiterated by analysts at JMP Securities. The firm currently has a $12.50 target price on the stock.

RLI (NYSE:RLI) had its market perform rating reiterated by analysts at JMP Securities.

Rotork (LON:ROR) had its overweight rating reissued by analysts at JPMorgan Chase & Co.. They currently have a GBX 390 ($4.80) price target on the stock.

SmartFinancial (NASDAQ:SMBK) had its strong-buy rating reissued by analysts at Raymond James. Raymond James currently has a $42.00 target price on the stock, up from their previous target price of $36.00.

Sanara MedTech (NASDAQ:SMTI) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $50.00 target price on the stock.

Serica Energy (LON:SQZ) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 200 ($2.46) price target on the stock.

SSP Group (LON:SSPG) had its house stock rating reaffirmed by analysts at Shore Capital.

Spectris (LON:SXS) had its buy rating reissued by analysts at Shore Capital.

Symbotic (NASDAQ:SYM) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $60.00 target price on the stock.

Third Coast Bancshares (NASDAQ:TCBX) had its overweight rating reaffirmed by analysts at Stephens. Stephens currently has a $42.00 target price on the stock.

Triumph Financial (NASDAQ:TFIN) had its equal weight rating reissued by analysts at Stephens. They currently have a $109.00 price target on the stock.

Team17 Group (LON:TM17) had its buy rating reissued by analysts at Shore Capital.

Titon (LON:TON) had its house stock rating reaffirmed by analysts at Shore Capital.

TowneBank (NASDAQ:TOWN) had its equal weight rating reissued by analysts at Stephens. They currently have a $41.00 target price on the stock.

TriMas (NASDAQ:TRS) had its buy rating reaffirmed by analysts at BWS Financial. BWS Financial currently has a $40.00 price target on the stock.

Travelers Companies (NYSE:TRV) had its sector perform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $268.00 target price on the stock, down from their previous target price of $273.00.

Two Harbors Investment (NYSE:TWO) had its market outperform rating reiterated by analysts at JMP Securities. The firm currently has a $14.00 target price on the stock.

United Airlines (NASDAQ:UAL) had its outperform rating reissued by analysts at Raymond James. Raymond James currently has a $130.00 target price on the stock, up from their previous target price of $120.00.

UroGen Pharma (NASDAQ:URGN) had its buy rating reissued by analysts at D. Boral Capital. D. Boral Capital currently has a $25.00 price target on the stock.

Univest Financial (NASDAQ:UVSP) had its equal weight rating reaffirmed by analysts at Stephens. Stephens currently has a $31.00 target price on the stock.

Vigil Neuroscience (NASDAQ:VIGL) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $17.00 price target on the stock.

WesBanco (NASDAQ:WSBC) had its equal weight rating reaffirmed by analysts at Stephens. They currently have a $39.00 target price on the stock.

Wintrust Financial (NASDAQ:WTFC) had its strong-buy rating reissued by analysts at Raymond James. Raymond James currently has a $150.00 target price on the stock, up from their previous target price of $135.00.

Wintrust Financial (NASDAQ:WTFC) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $152.00 target price on the stock.

Receive News & Ratings for Apple Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apple Inc and related companies with MarketBeat.com's FREE daily email newsletter.